➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Express Scripts

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Talampanel

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Talampanel?

Talampanel is an investigational drug.

There have been 11 clinical trials for Talampanel. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2005.

The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and Parkinson Disease. The leading clinical trial sponsors are Teva Pharmaceutical Industries, National Cancer Institute (NCI), and National Institute of Neurological Disorders and Stroke (NINDS).

Recent Clinical Trials for Talampanel
A Phase 1 Study to Investigate the Effects of Talampanel on the Heart RhythmCetero Research, San AntonioPhase 1
A Phase 1 Study to Investigate the Effects of Talampanel on the Heart RhythmTeva Pharmaceutical IndustriesPhase 1
Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)Teva Pharmaceutical IndustriesPhase 2

See all Talampanel clinical trials

Clinical Trial Summary for Talampanel

Top disease conditions for Talampanel
Top clinical trial sponsors for Talampanel

See all Talampanel clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.